Home > Financial Ratios > BIOCON
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 44.2132.2814.458.0914.72

What is the latest Core EBITDA Growth ratio of BIOCON ?

The latest Core EBITDA Growth ratio of BIOCON is 44.21 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202444.21
Mar202332.28
Mar202214.45
Mar20218.09
Mar202014.72

How is Core EBITDA Growth of BIOCON Trending?

Years Core EBITDA Growth % Change
Mar2024 44.21
36.96
Mar2023 32.28
123.39
Mar2022 14.45
78.62
Mar2021 8.09
-45.04
Mar2020 14.72 -

Other Financial Ratios of BIOCON


Compare Core EBITDA Growth ratio of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹41,090.5 Cr -1.7% 13.1% 28.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,306.0 Cr -2.5% 7.6% 4.7% Stock Analytics
DIVIS LABORATORIES ₹150,343.0 Cr -3% 3.4% 61.5% Stock Analytics
CIPLA ₹117,323.0 Cr -1.6% 3% -3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹108,619.0 Cr -0.3% 9% 22.3% Stock Analytics
DR REDDYS LABORATORIES ₹95,941.5 Cr -1.2% 2.9% -6.4% Stock Analytics


BIOCON Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-1.7%

13.1%

28.4%

SENSEX

-1.8%

2.7%

5%


You may also like the below Video Courses